Wael A. Alanazi, Turki Alharbi, Doaa M. El-Nagar, Abdullah M. Albogami, & Mohammed Alswayyed. (2023). Dapagliflozin Mitigates Hypotension in Lipopolysaccharide-Induced Acute Inflammation Independent of Glycemia Level. MDPI AG.
Chicago Style (17th ed.) CitationWael A. Alanazi, Turki Alharbi, Doaa M. El-Nagar, Abdullah M. Albogami, and Mohammed Alswayyed. Dapagliflozin Mitigates Hypotension in Lipopolysaccharide-Induced Acute Inflammation Independent of Glycemia Level. MDPI AG, 2023.
MLA (9th ed.) CitationWael A. Alanazi, et al. Dapagliflozin Mitigates Hypotension in Lipopolysaccharide-Induced Acute Inflammation Independent of Glycemia Level. MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.